The Dutch government removes Germany from its international reference pricing
The Rijksoverheid (Government of the Netherlands) has announced that Germany is no longer part of its international reference pricing basket. … read more »
BPI Chief Executive: rebates lead to medicine shortages
The BPI – Bundesverband der Pharmazeutischen Industrie (The Federal Association of the Pharmaceutical Industry) has continued its criticism of the … read more »
G-BA and healthcare community call for tighter regulations of unlicensed high-cost medicines
The G-BA – The Gemeinsamer Bundesausschuss (Federal Joint Committee) and the wider healthcare community have called for stricter regulations of … read more »
BPI calls for more spending on Germany’s outpatient sector
Dr. Kai Joachimsen, the Chief Executive of BPI – Der Bundesverband der Pharmazeutischen Industrie (Federal Association of the Pharmaceutical Industry) … read more »
Doctors in Germany to be able to prescribe mobile health applications
The German Government has recently adopted a law that will allow the prescription of mobile health applications with statutory health … read more »
BPI argue GSAV passed without sufficient challenge
The Bundesrat did not use its opportunity to challenge aspects of GSAV legislation when it approved it earlier this year, … read more »
BPI calls for end to price freeze
The German Preismoratorium has been challenged by the BPI as ineffective and without basis. The association of the German pharmaceutical … read more »
Germany and France sign MOSAR agreement
Germany and France have signed the MOSAR agreement which aims to increase patient access to healthcare services. Under the agreement, … read more »
Final day of the World Advanced Therapies & Regenerative Medicine Congress 2019
Today has seen a busy final day of the World Advanced Therapies & Regenerative Medicine Congress 2019 in London. MAP … read more »
Amendments to the GSAV Bill: Vaccinations, Orphan drug registries, Biosimilars, ATMPs
The political parties CDU/CSU and SPD have agreed on significant changes on the GSAV Bill currently pending in the German … read more »
